Autoantibodies Arthritis Autoimmune diseases Multidisciplinarity Inflammation B-lymphocyte Male Antibodies Gene therapy Acute Kidney Injury/epidemiology/etiology Data integration COVID-19 B cell homeostasis Adverse drug reactions AAV vectors Polymyositis AAV humoral immunity Humans Case reports Prognosis Anti-Mi2 CD8+T cells Inborn errors of metabolism Myopathy Biomarkers Dermatomyositis Amyotrophy Inclusion body myositis Agalsidase Animals Adjudication Idiopathic inflammatory myopathies Inflammatory myopathy Anti-agalsidase antibodies Anti‐mitochondrial antibodies Outcome measures AAV vector Auto-immunité Adeno-associated vector Interferon Anti-synthetase syndrome Lysosomal storage diseases Myocarditis Anti-drug antibodies CD8+ T-bet+ cells Assisted communication devices Deep immune profiling Auto-antibodies IBM Active Muscle Aldostérone DM Antisynthétase Dependovirus/genetics/immunology IMNM Female Immunotherapy Middle Aged Bioelectrical impedance analysis Myositis and muscle disease Acid-alpha-glucosidase Biopsy Adeno-associated virus Autoantibody Anticorps anti-agalsidase Sphingosine-1-phosphate Interstitial lung disease Antisynthetase Biomarqueurs Antiphospholipid syndrome Aldosterone Immune checkpoint inhibitors Antibody responses Anti-MDA5 autoantibodies Skeletal muscle Antisynthetase syndrome Auto‐antibodies Myositis Cytokines AAV Anémie hémolytique Analyses multidimensionnelles Machine learning Biomarker Adolescence Anticorps spécifique des myosites Cancer Autoimmunity Adeno-associated virus vector AAV antibody Aged Anti-IgE IgG Mass cytometry Systems biology Abnormal movement Anti-interleukin-6 Fabry disease Amyotrophic lateral sclerosis Adult